Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sanja A. Farkas, Bengt G. Sorbe & Torbjörn K. Nilsson. (2017) Epigenetic changes as prognostic predictors in endometrial carcinomas. Epigenetics 12:1, pages 19-26.
Read now
Read now
Thanh H Dellinger, Kestutis Planutis, Krishnansu S Tewari & Randall F Holcombe. (2012) Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Review of Anticancer Therapy 12:1, pages 51-62.
Read now
Read now
Articles from other publishers (63)
Kamthorn Pruksananonda, Artisa Wasinarom & Apiwat Mutirangura. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease
959
986
.
Deepa Bisht, Mridula Bhadra, Nikita Sharma & Manisha Sachan. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease
931
957
.
Lingli Chen, Xingyu Zheng, Wenlu Liu, Yiqing Sun, Shuangshuang Zhao, Lina Tian, Wenyan Tian, Fengxia Xue, Chunsheng Kang & Yingmei Wang. (2023) Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR—EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer. Cancer Letters 578, pages 216445.
Crossref
Crossref
Huanzhen Zhou, Yingzhi Zhang, Jing Jin, Kewei Shen, Yang Yang & Peiwei Lao. (2023) Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA‐sequencing and methylation modification data in endometrial cancer. The Journal of Gene Medicine.
Crossref
Crossref
Chunxue Zhang, Yaru Sheng, Xiao Sun & Yudong Wang. (2023) New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. Cancer and Metastasis Reviews 42:3, pages 891-925.
Crossref
Crossref
Louis Y El Khoury, Wan Hsin Lin, James B Smadbeck, Michael T Barrett, Dorsay Sadeghian, Alexa F McCune, Giannoula Karagouga, John C Cheville, Faye R Harris, Lindsey M Kinsella, Ryan W Feathers, Janet L Schafer Klein, Marina RS Walther-Antonio, Sarah H Johnson, Alan R Penheiter, Giuseppe Cucinella, Gabriella Schivardi, Aditya Bhagwate, Mitesh J Borad, Aaron S Mansfield, Stephen J Murphy, Andrea Mariani, George Vasmatzis, Panos Z Anastasiadis, Saravut J Weroha & Alyssa M Larish. (2023)
Epigenomics may begin to explain
in vitro
differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer
. Epigenomics 15:5, pages 283-292.
Crossref
Crossref
Weike Li, Rufei Gao, Yubin Ding, Xuemei Chen, Xueqing Liu, Junlin He, Fangfang Li, Jing Long, Siyu Lu, Chengshun Yang & Yingxiong Wang. (2022) Imbalance hepatic metabolism homeostasis in the F1 generation of endometrial DNMT3B conditional knockout female mice. Frontiers in Physiology 13.
Crossref
Crossref
Ting Xu, Hongmei Ding, Jie Chen, Jiahui Lei, Meng Zhao, Bingyu Ji, Youguo Chen, Songbing Qin & Qinqin Gao. (2022) Research Progress of DNA Methylation in Endometrial Cancer. Biomolecules 12:7, pages 938.
Crossref
Crossref
Po-Chien Shen, Ying-Fu Wang, Hao-Chih Chang, Wen-Yen Huang, Cheng-Hsiang Lo, Yu-Fu Su, Jen-Fu Yang, Chun-Shu Lin & Yang-Hong Dai. (2022) Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology.
Crossref
Crossref
Vishakha Mahajan, Palak Gujral, Lekha Jain & Anna P. Ponnampalam. (2022) Differential Expression of Steroid Hormone Receptors and Ten Eleven Translocation Proteins in Endometrial Cancer Cells. Frontiers in Oncology 12.
Crossref
Crossref
Adrian Po Zhu Li & Dulmini Kariyawasam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
225
243
.
Zhenhai Li & Yuanyuan Li. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
595
610
.
Tao Gui, Ming Liu, Bing Yao, Haiqin Jiang, Dongjun Yang, Qixiang Li, Xiangwei Zeng, Ying Wang, Jian Cao, Yexuan Deng, Xinyu Li, Peipei Xu, Liqin Zhou, Dake Li, Zhihui Wang, Ke Zen, David C. S. Huang, Bing Chen, Guiping Wan & Quan Zhao. (2021) TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death & Differentiation 28:12, pages 3316-3328.
Crossref
Crossref
Kadie Edwards, Seydou Yao, Simone Pisano, Veronica Feltracco, Katja Brusehafer, Sumanta Samanta, Oommen P. Oommen, S. Andrea Gazze, Roberta Paravati, Holly Maddison, Chao Li, Deyarina Gonzalez, R. Steven Conlan & Lewis Francis. (2021) Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer Models. Cancers 13:16, pages 4032.
Crossref
Crossref
Srikumar Chakravarthi & Barani Karikalan. (2021) Molecular Biomarkers for Lung Adenocarcinoma: A Short Review. Current Cancer Therapy Reviews 17:2, pages 97-106.
Crossref
Crossref
Futaba Inoue, Kenbun Sone, Yusuke Toyohara, Yu Takahashi, Asako Kukita, Aki Hara, Ayumi Taguchi, Michihiro Tanikawa, Tetsushi Tsuruga & Yutaka Osuga. (2021) Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications. International Journal of Molecular Sciences 22:5, pages 2305.
Crossref
Crossref
Kun Zhang, Yan Liu, Xiaodan Liu, Juan Du, Yuxiang Wang, Jing Yang, Yingxian Li & Congrong Liu. (2021) Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. Pathology 53:2, pages 179-186.
Crossref
Crossref
Adam S. Neal, Miguel Nunez, Tiffany Lai, Anela Tosevska, Marco Morselli, Malaika Amneus, Mae Zakhour, Neda A. Moatamed, Matteo Pellegrini & Sanaz Memarzadeh. (2020) Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia. Reproductive Sciences 27:9, pages 1778-1790.
Crossref
Crossref
Chiujung Yang, Natsuki Ota-Kurogi, Kazuhiro Ikeda, Toshiyuki Okumura, Kuniko Horie-Inoue, Satoru Takeda & Satoshi Inoue. (2020) MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC. The Journal of Biochemistry 168:1, pages 7-14.
Crossref
Crossref
Li Zhang, Suet Ying Kwan, Kwong Kwok Wong, Pamela T. Soliman, Karen H. Lu & Samuel C. Mok. (2020) Pathogenesis and Clinical Management of Uterine Serous Carcinoma. Cancers 12:3, pages 686.
Crossref
Crossref
Francesco Multinu, Jun Chen, Joseph D. Madison, Michelle Torres, Jvan Casarin, Daniel Visscher, Viji Shridhar, Jamie Bakkum-Gamez, Mark Sherman, Nicolas Wentzensen, Andrea Mariani & Marina Walther-Antonio. (2020) Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. Gynecologic Oncology 156:3, pages 682-688.
Crossref
Crossref
Yongchao Dou, Emily A. Kawaler, Daniel Cui Zhou, Marina A. Gritsenko, Chen Huang, Lili Blumenberg, Alla Karpova, Vladislav A. Petyuk, Sara R. Savage, Shankha Satpathy, Wenke Liu, Yige Wu, Chia-Feng Tsai, Bo Wen, Zhi Li, Song Cao, Jamie Moon, Zhiao Shi, MacIntosh Cornwell, Matthew A. Wyczalkowski, Rosalie K. Chu, Suhas Vasaikar, Hua Zhou, Qingsong Gao, Ronald J. Moore, Kai Li, Sunantha Sethuraman, Matthew E. Monroe, Rui Zhao, David Heiman, Karsten Krug, Karl Clauser, Ramani Kothadia, Yosef Maruvka, Alexander R. Pico, Amanda E. Oliphant, Emily L. Hoskins, Samuel L. Pugh, Sean J.I. Beecroft, David W. Adams, Jonathan C. Jarman, Andy Kong, Hui-Yin Chang, Boris Reva, Yuxing Liao, Dmitry Rykunov, Antonio Colaprico, Xi Steven Chen, Andrzej Czekański, Marcin Jędryka, Rafał Matkowski, Maciej Wiznerowicz, Tara Hiltke, Emily Boja, Christopher R. Kinsinger, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, David Mutch, Katherine Fuh, Matthew J. Ellis, Deborah DeLair, Mathangi Thiagarajan, D.R. Mani, Gad Getz, Michael Noble, Alexey I. Nesvizhskii, Pei Wang, Matthew L. Anderson, Douglas A. Levine, Richard D. Smith, Samuel H. Payne, Kelly V. Ruggles, Karin D. Rodland, Li Ding, Bing Zhang, Tao Liu, David Fenyö, Anupriya Agarwal, Meenakshi Anurag, Dmitry Avtonomov, Chet Birger, Michael J. Birrer, Simina M. Boca, William E. Bocik, Uma Borate, Melissa Borucki, Meghan C. Burke, Shuang Cai, Anna Calinawan, Steven A. Carr, Sonya Carter, Patricia Castro, Sandra Cerda, Michelle Chaikin, Daniel W. Chan, Doug Chan, Alyssa Charamut, Feng Chen, Jin Chen, Lijun Chen, Lin S. Chen, David Chesla, Milan G. Chheda, Arul M. Chinnaiyan, Shrabanti Chowdhury, Marcin P. Cieslik, David J. Clark, Sandra Cottingham, Houston Culpepper, Jacob Day, Stephanie De Young, Emek Demir, Saravana Mohan Dhanasekaran, Rajiv Dhir, Marcin J. Domagalski, Peter Dottino, Brian Druker, Elizabeth Duffy, Maureen Dyer, Nathan J. Edwards, Robert Edwards, Kim Elburn, Jayson B. Field, Alicia Francis, Stacey Gabriel, Yifat Geffen, Daniel Geiszler, Michael A. Gillette, Andrew K. Godwin, Pamela Grady, Linda Hannick, Pushpa Hariharan, Sue Hilsenbeck, Barbara Hindenach, Katherine A. Hoadley, Runyu Hong, Galen Hostetter, James J. Hsieh, Yingwei Hu, Michael M. Ittmann, Eric Jaehnig, Scott D. Jewell, Jiayi Ji, Corbin D. Jones, Renee Karabon, Karen A. Ketchum, Munziba Khan, Beom-Jun Kim, Azra Krek, Tanya Krubit, Chandan Kumar-Sinha, Felipe D. Leprevost, Michael Lewis, Qing Kay Li, Yize Li, Hongwei Liu, Jan Lubinski, Weiping Ma, Rashna Madan, Ewa Malc, Anna Malovannaya, Sailaja Mareedu, Sanford P. Markey, Annette Marrero-Oliveras, John Martignetti, Jason McDermott, Peter B. McGarvey, John McGee, Piotr Mieczkowski, Francesmary Modugno, Rebecca Montgomery, Chelsea J. Newton, Gilbert S. Omenn, Amanda G. Paulovich, Amy M. Perou, Francesca Petralia, Paul Piehowski, Larisa Polonskaya, Liqun Qi, Shannon Richey, Karna Robinson, Nancy Roche, Daniel C. Rohrer, Eric E. Schadt, Michael Schnaubelt, Yan Shi, Tara Skelly, Lori J. Sokoll, Xiaoyu Song, Stephen E. Stein, James Suh, Donghui Tan, Darlene Tansil, Guo Ci Teo, Ratna R. Thangudu, Cristina Tognon, Elie Traer, Jeffrey Tyner, Ki Sung Um, Dana R. Valley, Negin Vatanian, Pankaj Vats, Uma Velvulou, Michael Vernon, Liang-Bo Wang, Ying Wang, Alex Webster, Thomas Westbrook, David Wheeler, Jeffrey R. Whiteaker, George D. Wilson, Yuriy Zakhartsev, Robert Zelt, Hui Zhang, Yuping Zhang, Zhen Zhang & Grace Zhao. (2020) Proteogenomic Characterization of Endometrial Carcinoma. Cell 180:4, pages 729-748.e26.
Crossref
Crossref
Vishakha Mahajan, Cynthia Farquhar & Anna P. Ponnampalam. (2019) Could DNA hydroxymethylation be crucial in influencing steroid hormone signaling in endometrial biology and endometriosis?. Molecular Reproduction and Development 87:1, pages 7-16.
Crossref
Crossref
Yannan Bin, Xiaojuan Wang, Le Zhao, Pengbo Wen & Junfeng Xia. (2019) An analysis of mutational signatures of synonymous mutations across 15 cancer types. BMC Medical Genetics 20:S2.
Crossref
Crossref
Masaru Nagashima, Naofumi Miwa, Hajime Hirasawa, Yukiko Katagiri, Ken Takamatsu & Mineto Morita. (2019) Genome-wide DNA methylation analysis in obese women predicts an epigenetic signature for future endometrial cancer. Scientific Reports 9:1.
Crossref
Crossref
Lanxuan Liu, Ting Shi, Kendall N. Houk & Yi-Lei Zhao. (2019) Understanding the R882H mutation effects of DNA methyltransferase DNMT3A: a combination of molecular dynamics simulations and QM/MM calculations. RSC Advances 9:54, pages 31425-31434.
Crossref
Crossref
Xiao Huo, Hengzi Sun, Dongyan Cao, Jiaxin Yang, Peng Peng, Mei Yu & Keng Shen. (2019) Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data. Scientific Reports 9:1.
Crossref
Crossref
Yue Liu, Sanyuan Ma, Jiasong Chang, Tong Zhang, Xiaoxu Chen, Yan Liang & Qingyou Xia. (2019) Programmable targeted epigenetic editing using CRISPR system in Bombyx mori. Insect Biochemistry and Molecular Biology 110, pages 105-111.
Crossref
Crossref
Yao Wang, Dandan Liu, Xin Jin, Hongwei Song & Ge Lou. (2019) Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer. Pathology - Research and Practice 215:1, pages 137-143.
Crossref
Crossref
Golnaz Asaadi Tehrani. 2019. Computational Epigenetics and Diseases. Computational Epigenetics and Diseases
343
364
.
Thomas R. PisanicIIII, Leslie M. Cope, Shiou-Fu Lin, Ting-Tai Yen, Pornpat Athamanolap, Ryoichi Asaka, Kentaro Nakayama, Amanda N. Fader, Tza-Huei Wang, Ie-Ming Shih & Tian-Li Wang. (2018) Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions. Clinical Cancer Research 24:24, pages 6536-6547.
Crossref
Crossref
Alessandro La Ferlita, Rosalia Battaglia, Francesca Andronico, Salvatore Caruso, Antonio Cianci, Michele Purrello & Cinzia Di Pietro. (2018) Non-Coding RNAs in Endometrial Physiopathology. International Journal of Molecular Sciences 19:7, pages 2120.
Crossref
Crossref
Kamthorn Pruksananonda, Artisa Wasinarom & Apiwat Mutirangura. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease
781
802
.
Helen J. MacKay, Douglas A. Levine, Victoria L. Bae-Jump, Daphne W. Bell, Jessica N. McAlpine, Alessandro Santin, Gini F. Fleming, David G. Mutch, Kenneth P. Nephew, Nicolas Wentzensen, Paul J. Goodfellow, Oliver Dorigo, Hans W. Nijman, Russell Broaddus & Elise C. Kohn. (2017) Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget 8:48, pages 84579-84594.
Crossref
Crossref
Noel Pabalan, Anthicha Kunjantarachot, Chetana Ruangpratheep, Hamdi Jarjanazi, Denise Maria Christofolini, Caio Parente Barbosa & Bianca Bianco. (2017) Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis. Gynecologic Oncology 146:3, pages 603-608.
Crossref
Crossref
Carla Bartosch, José Manuel Lopes & Carmen Jerónimo. (2017) Epigenetics in endometrial carcinogenesis – part 1: DNA methylation. Epigenomics 9:5, pages 737-755.
Crossref
Crossref
Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam & Khadijeh Elmizadeh. (2017) Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients. International Journal of Cancer Management 10:4.
Crossref
Crossref
Madhu Bagaria, Emily Shields & Jamie N. Bakkum-Gamez. (2017) Novel approaches to early detection of endometrial cancer. Current Opinion in Obstetrics & Gynecology 29:1, pages 40-46.
Crossref
Crossref
Jie Zhang & Kun Huang. (2017) Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers. BMC Genomics 18:S1.
Crossref
Crossref
Peifeng Ruan, Jing Shen, Regina M. Santella, Shuigeng Zhou & Shuang Wang. (2016) NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals. Nucleic Acids Research 44:16, pages e134-e134.
Crossref
Crossref
Min Zhao, Yining Liu & Tracy A O'Mara. (2016) ECGene: A Literature‐Based Knowledgebase of Endometrial Cancer Genes. Human Mutation 37:4, pages 337-343.
Crossref
Crossref
Gavino Faa, Daniela Fanni, Giuseppina Pichiri & Clara Gerosa. 2016. Gynecological Cancers. Gynecological Cancers
3
22
.
Sheng-Mou Hsiao, Min-Wei Chen, Chi-An Chen, Ming-Hsien Chien, Kuo-Tai Hua, Michael Hsiao, Min-Liang Kuo & Lin-Hung Wei. (2015) The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Annals of Surgical Oncology 22:S3, pages 1556-1565.
Crossref
Crossref
Zheng Chen, Qi Che, Fei-Zhou Jiang, Hui-Hui Wang, Fang-Yuan Wang, Yun Liao & Xiao-Ping Wan. (2015) Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer. Biochemical and Biophysical Research Communications 463:4, pages 876-880.
Crossref
Crossref
Yasuko Suga, Tamotsu Sugai, Noriyuki Uesugi, Tomonori Kawasaki, Tomoyuki Fukagawa, Eiichiro Yamamoto, Kazuyuki Ishida, Hiromu Suzuki & Toru Sugiyama. (2015) Molecular analysis of isolated tumor glands from endometrial endometrioid adenocarcinomas. Pathology International 65:5, pages 240-249.
Crossref
Crossref
Jamie N. Bakkum-Gamez, Nicolas Wentzensen, Matthew J. Maurer, Kieran M. Hawthorne, Jesse S. Voss, Trynda N. Kroneman, Abimbola O. Famuyide, Amy C. Clayton, Kevin C. Halling, Sarah E. Kerr, William A. Cliby, Sean C. Dowdy, Benjamin R. Kipp, Andrea Mariani, Ann L. Oberg, Karl C. Podratz, Viji Shridhar & Mark E. Sherman. (2015) Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecologic Oncology 137:1, pages 14-22.
Crossref
Crossref
Mukesh Verma. 2015. Advances in Cancer Biomarkers. Advances in Cancer Biomarkers
59
80
.
Emily R Theisen, Snehal Gajiwala, Jared Bearss, Venkataswamy Sorna, Sunil Sharma & Margit Janat-Amsbury. (2014) Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma. BMC Cancer 14:1.
Crossref
Crossref
Lise M A De Strooper, Marjolein van Zummeren, Renske D M Steenbergen, Maaike C G Bleeker, Albertus T Hesselink, G Bea A Wisman, Peter J F Snijders, Daniëlle A M Heideman & Chris J L M Meijer. (2014)
CADM1
,
MAL
and
miR124-2
methylation analysis in cervical scrapes to detect cervical and endometrial cancer
. Journal of Clinical Pathology 67:12, pages 1067-1071.
Crossref
Crossref
Tatsuhiro Shibata & Hiroyuki Aburatani. (2014) Exploration of liver cancer genomes. Nature Reviews Gastroenterology & Hepatology 11:6, pages 340-349.
Crossref
Crossref
Erling A. Hoivik, Kanthida Kusonmano, Mari K. Halle, Anna Berg, Elisabeth Wik, Henrica M. J. Werner, Kjell Petersen, Anne M. Oyan, Karl-Henning Kalland, Camilla Krakstad, Jone Trovik, Martin Widschwendter & Helga B. Salvesen. (2014) Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Oncotarget 5:4, pages 1052-1061.
Crossref
Crossref
Shannon Masih, Lesley A. Plumptre & Young-In Kim. 2014. Molecular mechanisms and physiology of disease. Molecular mechanisms and physiology of disease
277
353
.
Allison Jones, Andrew E. Teschendorff, Quanxi Li, Jane D. Hayward, Athilakshmi Kannan, Tim Mould, James West, Michal Zikan, David Cibula, Heidi Fiegl, Shih-Han Lee, Elisabeth Wik, Richard Hadwin, Rupali Arora, Charlotte Lemech, Henna Turunen, P?ivi Pakarinen, Ian J. Jacobs, Helga B. Salvesen, Milan K. Bagchi, Indrani C. Bagchi & Martin Widschwendter. (2013) Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development. PLoS Medicine 10:11, pages e1001551.
Crossref
Crossref
Tjalling Bosse, Natalja T ter Haar, Laura M Seeber, Paul J v Diest, Frederik J Hes, Hans FA Vasen, Remi A Nout, Carien L Creutzberg, Hans Morreau & Vincent THBM Smit. (2013) Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. Modern Pathology 26:11, pages 1525-1535.
Crossref
Crossref
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F. McMichael, Matthew A. Wyczalkowski, Mark D. M. Leiserson, Christopher A. Miller, John S. Welch, Matthew J. Walter, Michael C. Wendl, Timothy J. Ley, Richard K. Wilson, Benjamin J. Raphael & Li Ding. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:7471, pages 333-339.
Crossref
Crossref
Roman Fiolka. (2013) Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncology Reports.
Crossref
Crossref
P. Dehan, C. Canon, G. Trooskens, M. Rehli, C. Munaut, W. Van Criekinge & P. Delvenne. (2013) Expression of Type 2 Orexin Receptor in Human Endometrium and Its Epigenetic Silencing in Endometrial Cancer. The Journal of Clinical Endocrinology & Metabolism 98:4, pages 1549-1557.
Crossref
Crossref
Yu-Li ChenKung-Liahng WangMin-Yu ChenMu-Hsien YuChen-Hsuan WuYu-Min KeYi-Jen ChenYin-Yi ChangKeng-Fu HsuMing-Shyen Yen. (2013) Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group. Journal of Gynecologic Oncology 24:1, pages 14.
Crossref
Crossref
J J Liu, A Hazra, E Giovannucci, S E Hankinson, B Rosner & I De Vivo. (2013) One-carbon metabolism factors and endometrial cancer risk. British Journal of Cancer 108:1, pages 183-187.
Crossref
Crossref
Martin Widschwendter, Allison Jones & Andrew E. Teschendorff. (2013) Epigenetics makes its mark on women-specific cancers—an opportunity to redefine oncological approaches?. Gynecologic Oncology 128:1, pages 134-143.
Crossref
Crossref
Paul Nioi. 2012. Toxicology and Epigenetics. Toxicology and Epigenetics
615
630
.
Qian Hu, Li Yu, Rui Chen, Yan-ling Wang, Lei Ji, Yan Zhang, Ya Xie & Qin-ping Liao. (2012) 5-Aza-2′-Deoxycytidine Improves the Sensitivity of Endometrial Cancer Cells to Progesterone Therapy. International Journal of Gynecological Cancer 22:6, pages 951-959.
Crossref
Crossref
Sun-Wei Guo. (2012) The endometrial epigenome and its response to steroid hormones. Molecular and Cellular Endocrinology 358:2, pages 185-196.
Crossref
Crossref